• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Utility of measuring the serum concentration of antituberculous drugs in patient with pulmonary tuberculosis

Research Project

Project/Area Number 23790916
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Respiratory organ internal medicine
Research InstitutionTohoku University (2014)
Fukushima Medical University (2011-2013)

Principal Investigator

OSHIMA Kengo  東北大学, 大学病院, 助教 (30453012)

Project Period (FY) 2011-04-28 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Keywords抗結核薬 / 血中濃度 / 排菌期間 / NAT2遺伝子 / SNP / 肺結核症 / インターフェロンガンマ / 遺伝子多型 / 肺結核 / 病型分類
Outline of Final Research Achievements

We measured the serum concentration of Isoniazid (INH) and Rifampicin (RIF), and analyzed single neucleotide polymorphism (SNP)of N-acetyltransferase 2 (NAT2) genein 29 patients with pulmonary tuberculosis who admitted to Fukushima Medical University Hospital. Serum concentration of INH two hours after administration was 2.5±1.3(average ± standard deviation)μg/ml and that of RIF was 6.8±4.3μg/ml. Analysis of SNP of NAT2 gene shwoed that 15 patients are rapid acetylator of INH, and 11 patients are intermediate acetylator and three patients are slowacetylator in these 29 patients. Statistical analysis showed that the amount of expectorated acid-fast bacilli (AFB) at the beginning of treatment is larger, the period of expectoration of AFB in these patients is longer significantly and the patients whose serum concentration of RIF is over 4.0μg/ml tend to shorten the period of expectoration of AFB.

Report

(5 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (1 results)

All 2012

All Presentation (1 results)

  • [Presentation] 抗結核薬(INH, RFP)の血中濃度と治療効果についての検討2012

    • Author(s)
      大島謙吾
    • Organizer
      結核・非定型抗酸菌症治療研究会
    • Place of Presentation
      東京
    • Related Report
      2012 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi